Literature DB >> 30045865

Pulmonary Tuberculosis Conversion Documented by Microscopic Staining for Detection of Dynamic, Dormant, and Dead Mycobacteria (DDD Staining).

A Loukil1, F Darriet-Giudicelli1, C Eldin1,2, M Drancourt3.   

Abstract

Entities:  

Keywords:  Mycobacterium tuberculosis; dormancy; fluorescence microscopy; pulmonary tuberculosis

Mesh：

Substances：

Year:  2018        PMID： 30045865      PMCID： PMC6156299          DOI： 10.1128/JCM.01108-18

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


× No keyword cloud information.
  14 in total

1.  [Application of FDA/EB staining for the detection of viable or non-viable mycobacteria in clinical specimens].

Authors:  S Harada; N Numata
Journal:  Kekkaku       Date:  1992-02

2.  Susceptibility testing of Mycobacterium tuberculosis: comparison of the BACTEC TB-460 method and flow cytometric assay with the proportion method.

Authors:  D J DeCoster; R M Vena; S M Callister; R F Schell
Journal:  Clin Microbiol Infect       Date:  2005-05       Impact factor: 8.067

3.  In vivo adaptation of the Wayne model of latent tuberculosis.

Authors:  Lisa Woolhiser; Marcela Henao Tamayo; Baolin Wang; Veronica Gruppo; John T Belisle; Anne J Lenaerts; Randall J Basaraba; Ian M Orme
Journal:  Infect Immun       Date:  2007-02-05       Impact factor: 3.441

Review 4.  Acid-Fast Positive and Acid-Fast Negative Mycobacterium tuberculosis: The Koch Paradox.

Authors:  Catherine Vilchèze; Laurent Kremer
Journal:  Microbiol Spectr       Date:  2017-03

5.  Differential influence of nutrient-starved Mycobacterium tuberculosis on adaptive immunity results in progressive tuberculosis disease and pathology.

Authors:  Jes Dietrich; Sugata Roy; Ida Rosenkrands; Thomas Lindenstrøm; Jonathan Filskov; Erik Michael Rasmussen; Joseph Cassidy; Peter Andersen
Journal:  Infect Immun       Date:  2015-09-28       Impact factor: 3.441

6.  A fluorescent staining procedure for determining the viability of mycobacterial cells.

Authors:  J T Kvach; J R Veras
Journal:  Int J Lepr Other Mycobact Dis       Date:  1982-06

7.  A novel in vitro multiple-stress dormancy model for Mycobacterium tuberculosis generates a lipid-loaded, drug-tolerant, dormant pathogen.

Authors:  Chirajyoti Deb; Chang-Muk Lee; Vinod S Dubey; Jaiyanth Daniel; Bassam Abomoelak; Tatiana D Sirakova; Santosh Pawar; Linda Rogers; Pappachan E Kolattukudy
Journal:  PLoS One       Date:  2009-06-29       Impact factor: 3.240

8.  Clinical evaluation of tuberculosis viability microscopy for assessing treatment response.

Authors:  Sumona Datta; Jonathan M Sherman; Marjory A Bravard; Teresa Valencia; Robert H Gilman; Carlton A Evans
Journal:  Clin Infect Dis       Date:  2014-12-23       Impact factor: 9.079

9.  Pharmacodynamic Modeling of Bacillary Elimination Rates and Detection of Bacterial Lipid Bodies in Sputum to Predict and Understand Outcomes in Treatment of Pulmonary Tuberculosis.

Authors:  Derek J Sloan; Henry C Mwandumba; Natalie J Garton; Saye H Khoo; Anthony E Butterworth; Theresa J Allain; Robert S Heyderman; Elizabeth L Corbett; Mike R Barer; Geraint R Davies
Journal:  Clin Infect Dis       Date:  2015-03-16       Impact factor: 9.079

10.  Cytological and transcript analyses reveal fat and lazy persister-like bacilli in tuberculous sputum.

Authors:  Natalie J Garton; Simon J Waddell; Anna L Sherratt; Su-Min Lee; Rebecca J Smith; Claire Senner; Jason Hinds; Kumar Rajakumar; Richard A Adegbola; Gurdyal S Besra; Philip D Butcher; Michael R Barer
Journal:  PLoS Med       Date:  2008-04-01       Impact factor: 11.069
View more
  2 in total

1.  Bead-captured Mycobacterium tuberculosis for next-generation sequencing diagnosis of uncultured tuberculosis.

Authors:  Jamal Saad; Ahmed Loukil; Michel Drancourt
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-10-14       Impact factor: 3.267

2.  Mycobacterium ulcerans Experimental Dormancy.

Authors:  Ahmed Loukil; Rym Lalaoui; Hervé Bogreau; Sofiane Regoui; Michel Drancourt; Nassim Hammoudi
Journal:  Am J Trop Med Hyg       Date:  2022-04-11       Impact factor: 3.707
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.